Therapy Market Research Reports & Industry Analysis

... by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding E3 Ubiquitin Protein Ligase Mdm2 (Double Minute 2 Protein or Hdm2 or Oncoprotein Mdm2 or p53 Binding Protein Mdm2 or MDM2 or EC 6.3.2.) development landscape Develop and ...

... Leucine Rich Repeat Serine/Threonine Protein Kinase 2 (Dardarin or LRRK2 or EC 2.7.11.1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

... by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Prostate Specific Antigen (Gamma Seminoprotein or Kallikrein 3 or P 30 Antigen or Semenogelase or KLK3 or EC 3.4.21.77) development landscape Develop and design ...

... emitters. Based on technologies, the radiation therapy market is segmented into external radiation therapy technologies, internal radiation therapies and systemic radiation therapy technologies. External radiation therapy technologies are further segmented into ...

... effectively by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Acyl CoA Desaturase (Fatty Acid Desaturase or Delta 9 Desaturase or Stearoyl CoA Desaturase or SCD or EC 1.14.19.1) development landscape Develop and design ...

... circumstances where treatment options are inadequate. The global proton therapy market is set to experience favorable growth driven by ... this market is constrained by challenges such as high cost of proton therapy, stringent regulations and barriers to implementation. The report “Global Proton Therapy Market: ...

Global Infectious Disease Therapeutics Market: Global infectious disease therapeutics market estimated to be valued US$ XX Mn in 2017 and poised to grow at CAGR of XX% over 2017-2023. Market for infectious disease therapeutics is projected to reach US$ XX Mn by 2023. Infectious diseases are caused by ...

Global Stem Cell Therapy Market: Global stem cell therapy market estimated to be valued US$ XX Mn in 2017 and poised to grow at CAGR of XX% over 2017-2023. Market for stem cell therapy is projected to reach US$ XX Mn by 2023. Stem cell therapy involves use of stem cells to treat various diseases ...

... cost of proton radiation therapy and stringent regulatory procedures may hamper the global proton therapy market over the forecast period. Market Scope: Global Proton Therapy Market Global proton therapy market is segmented ...

The global cancer therapeutics market should reach $172.6 billion by 2022 from $121 billion in 2017 at a ... at a CAGR of 7.6% for the period 2017-2022. The stomach cancer segment of the global cancer therapeutics market is expected to grow from $8.2 billion in 2017 to $11.9 billion in 2022 ...

Global Extracorporeal Shock Wave Therapy (ESWT) Market: Global Extracorporeal Shock Wave Therapy (ESWT) market estimated to be valued US$ XX Mn in 2017 and poised to grow at CAGR of XX% over 2017-2023. Market for Extracorporeal Shock Wave Therapy projected to reach US$ XX Mn by 2023 ...

... . The Thrombotic Thrombocytopenic Purpura (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Thrombotic Thrombocytopenic Purpura and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

... Fibrosis Therapeutics Market & Forecast (2014 – 2024) 2. Global Cystic Fibrosis Therapeutics Market - Major Marketed Products Sales & Forecast (2012 - 2024) 3. Global Cystic Fibrosis Therapeutics Market - Pharmacological Class Sales & Forecast (2015 – 2021) 4. By Geography - Cystic Fibrosis Therapeutics ...

... 2017 to 2024. Based on geography, the North America aromatherapy market is segmented into 3 geographical regions, such as, U.S., Mexico, Canada North America aromatherapy market competition by top players including Young Living ...

... ’s Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Leber’s Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) and features dormant and discontinued projects. The guide covers therapeutics under ...

... releases. The Liver Fibrosis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Liver Fibrosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

... releases. The Cachexia (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Cachexia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

... releases. The Fibrosis (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Fibrosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

... releases. The Dupuytren Contracture (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Dupuytren Contracture and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

... releases. The Hepatic - Colorectal Metastasis (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Hepatic - Colorectal Metastasis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

... releases. The Raynauds Disease (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Raynauds Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

... therapy centers as well as its elongated history of proton therapy. USA leads the Pediatric Proton Therapy Market globally USA has the highest pediatric proton therapy market ... and Japan. This report provides the data on USA Pediatric Proton Therapy Market & Patients numbers, in 36 Cancer Types. Out of these ...

... releases. The Hemorrhage (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Hemorrhage and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

... Points 1. Global Proton Therapy Actual & Potential Market Analysis (2010 - 2022) 2. Global Proton Therapy Actual & Potential Candidate Analysis (2010 - 2022) 3. Global Proton Therapy Market Share Analysis (2010 - 2022) 4. Global Proton Therapy Candidate Share Analysis (2010 - 2022) 5. Proton Therapy Actual & Potential Market - Regional ...

The Global Continuous Renal Replacement Therapy (CRRT) Market Analysis & Forecast Report 2017 is a professional and in-depth study on the current state of the Continuous Renal Replacement Therapy (CRRT) Market. The report ...

The Global Radiotherapy Market Analysis & Forecast Report 2017 is a professional and in-depth study on the current state of the Radiotherapy Market. The report analysis the global market of Radiotherapy by main manufactures and geographic ...

... by RNCOS titled, "Global Cystic Fibrosis Therapeutics Market Outlook 2022”, unfolds the market dynamics of the cystic fibrosis therapeutics market. According to this new research report, the market for cystic fibrosis therapeutics was valued at US$ 1.94 Billion ... for largest share in the total cystic fibrosis therapeutics market in 2016. Additionally, the report covers the geographic analysis of the global cystic fibrosis therapeutics market by segmenting into three major ...

The report on global microbiome therapeutics market evaluates the growth trends of the industry through historical study ... competitive landscape of the worldwide market with company profiles of key players such as Enterome Bioscience, MaaT Pharma, MicroBiome Therapeutics LLC, OpenBiome, Rebiotix, Inc ...

... pipeline guide Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency ...

... Mucopolysaccharidosis I (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) and features dormant and discontinued projects. The guide covers therapeutics under Development ...

... Mucopolysaccharidosis II (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) and features dormant and discontinued projects. The guide covers therapeutics under Development ...

... Mucopolysaccharidosis III (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) and features dormant and discontinued projects. The guide covers therapeutics under Development ...

... Multiple System Atrophy (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) and features dormant and discontinued projects. The guide covers therapeutics under Development ...

... Report The report entitled “Global Acne Treatment Market: (2017-2021 Edition)”, provides analysis of the global acne treatment market and its products, with detailed analysis of market size and growth in terms ... ) Executive Summary The global acne treatment market is growing rapidly over the years and is expected to increase further in the forecasted period (2017-2021). Global acne treatment is supported by a number of growth ...

... pipeline guide Brain Ischemia - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Brain Ischemia (Central Nervous System), complete with analysis by stage of development ...

... pipeline guide Melasma (Chlosma) - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Melasma (Chlosma) (Dermatology), complete with analysis by stage of development ...

... Adrenoleukodystrophy (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Adrenoleukodystrophy (Adrenomyeloneuropathy/Schilder-Addison Complex) and features dormant and discontinued projects. The guide covers therapeutics under Development ...

... Chronic Obstructive Pulmonary Disease (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Chronic Obstructive Pulmonary Disease (COPD) and features dormant and discontinued projects. The guide covers therapeutics under Development ...

... number of proton therapy centers. In Czech Republic, currently only 1 proton therapy center is operational. The Prague Proton Therapy Center opened its doors in 2012. iGATE RESEARCH report titled “Czech Republic Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy ...

... titled “Europe Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022” provides a comprehensive assessment of the fast-evolving, high-growth Proton Therapy Market. The ... 6 View Points 1. Europe Proton Therapy Actual & Potential Market Analysis (2010 - 2022) 2. Europe Proton Therapy Actual & Potential Candidate Analysis (2010 - 2022) 3. Europe Proton Therapy Market Share Analysis (2010 - 2022) 4. Europe Proton Therapy Candidate Share Analy

... . This is the 4th edition report on Proton Therapy Market by iGATE RESEARCH. The report titled “Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers, Start of Treatment, Specifications ... - Center Wise Analysis 10. Proton Therapy Company Analysis 11. Proton Therapy Market - Growth Drivers and Challenges Global Proton Therapy Market (Actual & Potential) and Candidate Analysis, List of proton Therapy Centers, Start of Treatment ...

... in Switzerland that can treat a limited number of patients each year due to the gap in demand and supply. iGATE RESEARCH report titled “Switzerland Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022” provides a comprehensive assessment of the fast-evolving, high-growth Proton Therapy Market. This ...

... service two new national proton therapy centers in the UK. iGATE RESEARCH report titled “United Kingdom Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022” provides a comprehensive assessment of the fast-evolving, high-growth Proton Therapy Market. This ...

... Adrenocortical Carcinoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Adrenocortical Carcinoma (Adrenal Cortex Cancer) and features dormant and discontinued projects. The guide covers therapeutics under Development ...

... Basal Cell Carcinoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Basal Cell Carcinoma (Basal Cell Epithelioma) and features dormant and discontinued projects. The guide covers therapeutics under Development ...

... Chagas Disease (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Chagas Disease (American Trypanosomiasis) and features dormant and discontinued projects. The guide covers therapeutics under Development ...

... Clostridium difficile Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Clostridium difficile Infections (Clostridium difficile Associated Disease) and features dormant and discontinued projects. The guide covers therapeutics under Development ...

... to proton therapy is limited for a vast population, owing to a low number of proton therapy centers. In France, currently only 2 proton therapy centers are operational. iGATE RESEARCH report titled “France Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and ...

... proton therapy. The number of patients treated with proton therapy in Germany is very low whereas; the potential candidates for proton therapy are huge. iGATE RESEARCH report titled “Germany Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy ...

... in Italy, and technological advances are expected to give a boost to the domestic proton therapy marketplace. iGATE RESEARCH report titled “Italy Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022” provides a comprehensive assessment of the fast-evolving, high-growth Proton Therapy Market. This ...